Trimodality Therapy Is Tolerable and Feasible in Patients With Postprostatectomy High-Risk Pathologic (p) T2-3N0M0 Prostate Cancer: Results of a Phase 1-2 Trial
| Autor: | Kumar, P., Veldhuizen, P., Thompson, M., Shen, X., Pinski, J. |
|---|---|
| Zdroj: | In International Journal of Radiation Oncology, Biology, Physics 1 October 2016 96(2) Supplement:S186-S186 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|